The Bill & Melinda Gates Foundation is trying to get more biotech entrepreneurs to work on global health, and it just hired another venture capitalist to give the initiative a boost: Dr. Charlotte Hubbert. Charlotte, who did postdoctoral research on stem cells in the University of Washington lab of Randall Moon (2006-2009), is the second biotech VC to join the Gates Foundation in the past year. Charlotte's most recent career, prior to accepting the Gates Foundation position, was Vice President at H.I.G. BioVentures in Miami, Florida. The position at the Gates Foundation will represent a return "home" to Seattle for Charlotte, her husband Stefan and their son, Henry.
Here's what Hubbert said in a note to friends and colleagues this morning:
I am excited to work with Bob More and the Program Related Investments team to apply the principles and rigor of venture capital investing to support the Gates Foundation initiatives in Global Health. I believe this is a unique and unprecedented opportunity to support the best and brightest entrepreneurs in our community to tackle the diseases and issues that impact the poorest in the world. While [the foundation has] a mission of singular dedication, I see great potential for synergy with issues relevant to biotech globally. I look forward to continuing to work within the venture community to identify great ideas and entrepreneurs, and build great companies in support of these goals. When asked what Hubbert brings to the foundation, More said: “Scientific acumen, VC experience, empathy for the difficulty of starting up companies. And she seems like a nice person.” [Updated comment: 1:10 pm PT] Robert Nelsen, managing director of Arch Venture Partners, added: “They both have fantastic reputations and with Bob’s leadership of the group, experience and VC contacts and Charlotte’s energy I expect great things.”
News item text from Xcomony website, Luke Timmerman, National Biotech Editor of Xconomy.
Four students in Pharmacology Department laboratories, Alipi Naydenov, Michelle Oeser, Mario Rosasco, and Jenn Whiting, attended the Kobe University – University of Washington Joint Symposium on Integrative Membrane Biology and Signal Transduction Medicine, which was held December 13-14 in Kobe, Japan. In parallel to the sister city relationship Seattle has with the city of Kobe, UW and Kobe University have a sister school agreement. As part of Kobe University Global Center of Excellence Programs, 10 UW graduate students were invited to attend the two day meeting. The students attended talks, took part in a poster session, toured labs at Kobe University and traveled to Kyoto with students and faculty. Mario Rosasco received an award for his poster presentation.
Professor Neil Nathanson is one of nine UW-affiliated researchers that are among 539 new Fellows of the American Association for the Advancement of Science (AAAS). Election as a Fellow of AAAS is an honor bestowed upon members by their peers. Fellows are recognized for meritorious efforts to advance science or its applications.
Read more >>
Pharmacology Facebook page
UW Pharmacology now has a Facebook page
For graduate student alums, past postdoctoral fellows and staff that have been a part of the University of Washington Pharmacology Department, this will be a forum for connection, and also we, in the Department of Pharmacology, would like to know where you are and what you are doing!